Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells

MicroRNAs (miRNAs) are master regulators of drug resistance and have been previously proposed as potential biomarkers for the prediction of therapeutic response in colorectal cancer (CRC). Sorafenib, a multi-kinase inhibitor which has been approved for the treatment of liver, renal and thyroid cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Pehserl, Anna-Maria, Ress, Anna Lena, Stanzer, Stefanie, Resel, Margit, Karbiener, Michael, Stadelmeyer, Elke, Stiegelbauer, Verena, Gerger, Armin, Mayr, Christian, Scheideler, Marcel, Hutterer, Georg C., Bauernhofer, Thomas, Kiesslich, Tobias, Pichler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187811/
https://www.ncbi.nlm.nih.gov/pubmed/27916938
http://dx.doi.org/10.3390/ijms17122011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187811/
https://www.ncbi.nlm.nih.gov/pubmed/27916938
http://dx.doi.org/10.3390/ijms17122011

Ejemplares similares